GTA 6 Explained: What sets it apart, how saving works and how long it lasts
Grand Theft Auto VI launched on 19 November after repeated delays, bringing players back to Vice City with a new story, a vast open world and two p...
A new skin cancer drug has been developed using a genetically engineered virus that targets and replicates only cancer cells. That's according to public broadcaster NHK who said that researchers in Japan found that 77.8% of those tested, improved.
The experimental drug, created through collaboration between the University of Tokyo and Shinshu University, is part of a growing field known as 'viral therapy,' in which modified viruses are designed to selectively attack cancer cells.
Professor Todo Toshiki of the University of Tokyo and his team conducted trials on patients with an aggressive form of skin cancer to assess whether the treatment could be effective against other types of cancer as well.
Results showed that seven out of nine patients who received a combination of conventional treatment and the viral therapy improved, highlighting the potential of using both approaches together.
With no serious side effects reported so far, researchers plan to test the treatment on another nine patients to further evaluate its safety and efficacy.
Todo said the approach may offer a new option for patients who do not respond to existing treatments.
“If the treatment can be used for a variety of cancers, it could fundamentally change cancer treatment,” he added.
U.S. President Donald Trump, Russian President Vladimir Putin and Chinese President Xi Jinping are holding trilateral talks at the APEC summit in Shenzhen, China, with Ukraine, nuclear arms control and global security on the agenda.
U.S. President Donald Trump concluded his visit to the Philippines on Wednesday, 18 November, after holding bilateral talks with President Ferdinand Marcos Jr. in Manila. Trump had attended the ASEAN Summit gala as guest of honour the previous evening before departing for China.
U.S. President Donald Trump has joined Russian counterpart and leaders from across the Asia-Pacific region in Shenzhen for the 33rd Asia-Pacific Economic Cooperation (APEC) Summit, where trade, economic cooperation and AI are set to take centre stage.
Myanmar's security forces committed genocide against Rohingya Muslims during a brutal military crackdown in 2017 that killed thousands and involved widespread sexual violence, the United Nations' top court ruled on 19 November.
U.S. President Donald Trump, China's Xi Jinping and Russia's Vladimir Putin have issued a joint “declaration of peace” following historic talks in southern China, but stopped short of committing to nuclear arms reductions or addressing the war in Ukraine in their joint statement.
For the first time in more than a quarter of a century, the United States can no longer say it has eliminated measles as health experts warn the American outbreak reflects a collapse in trust in vaccines.
A new study in mice suggests the brain’s protective barrier does more than block harmful substances. It also delivers essential proteins from the body, a process that may break down early in Alzheimer’s disease and offer a new target for treatment.
Here's your AnewZ Daily Brief for the 5th of November, as health emergencies, humanitarian crises, political shifts, and cybersecurity threats put governments and essential services under pressure across the globe. Here are five stories worth your attention.
Kazakhstan plans to manufacture 494 types of medicines through eight major investment projects worth a combined $862 million, Health Minister Akmaral Alnazarova announced on 3 November, local media reported.
Dengue fever has killed more people in Bangladesh this year than in the whole of 2025, with October the deadliest month so far, data from Bangladesh's Health Ministry shows.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment